$VUZI
Vuzix Corp Stock $vuzi

$vuzi Overview Financials Valuation SEC Filings Company Website

2014 Q3 Form 10-Q Financial Statement

#000114420414050138 Filed on August 14, 2014

Income Statement

Concept	2014 Q3	2014 Q2	2013 Q4
Revenue	$664.6K	$723.3K	$610.0K
YoY Change	96.15%	3.29%	-14.08%
Cost Of Revenue	$460.2K	$462.2K	$650.0K
YoY Change	142.19%	13.68%	16.07%
Gross Profit	$204.4K	$261.0K	-$40.00K
YoY Change	37.34%	-11.09%	-126.67%
Gross Profit Margin	30.75%	36.09%	-6.56%
Selling, General & Admin	$929.0K	$789.3K	$900.0K
YoY Change	19.27%	-11.31%	4.65%
% of Gross Profit	454.61%	302.4%
Research & Development	$484.5K	$295.6K	$540.0K
YoY Change	3.02%	-29.8%	28.57%
% of Gross Profit	237.1%	113.23%
Depreciation & Amortization	$60.00K	$100.0K	$100.0K
YoY Change	-33.33%	11.11%	11.11%
% of Gross Profit	29.36%	38.31%
Operating Expenses	$1.414M	$1.085M	$1.530M
YoY Change	13.15%	157.68%	12.5%
Operating Profit	-$1.269M	-$925.3K	-$1.570M
YoY Change	6.09%	-16.48%	29.75%
Interest Expense	$66.33K	$25.47K	-$3.330M
YoY Change	-78.43%	-88.99%	1981.25%
% of Operating Profit
Other Income/Expense, Net	-$2.032M	$1.164M	$550.0K
YoY Change	207.63%	-312.15%
Pretax Income	-$3.301M	$239.1K	-$5.740M
YoY Change	77.81%	-114.43%	304.23%
Income Tax	$0.00	$0.00	-$40.00K
% Of Pretax Income		0.0%
Net Earnings	-$3.301M	$239.1K	-$5.700M
YoY Change	77.81%	-114.43%	301.41%
Net Earnings / Revenue	-496.75%	33.06%	-934.43%
Basic Earnings Per Share	-$0.31	$0.02
Diluted Earnings Per Share	-$312.5K	$0.02	-$591.3K
COMMON SHARES
Basic Shares Outstanding	10.56M shares	10.29M shares	9.541M shares
Diluted Shares Outstanding		11.23M shares

Balance Sheet

Concept	2014 Q3	2014 Q2	2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$600.0K	$2.000M	$300.0K
YoY Change	-76.92%	1900.0%	200.0%
Cash & Equivalents	$564.3K	$1.979M	$310.1K
Short-Term Investments
Other Short-Term Assets	$200.0K	$100.0K	$200.0K
YoY Change	100.0%	-75.0%	-33.33%
Inventory	$1.100M	$916.8K	$953.6K
Prepaid Expenses
Receivables	$100.0K	$166.1K	$214.9K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.000M	$3.115M	$1.680M
YoY Change	-42.22%	155.83%	38.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$400.0K	$353.6K	$446.3K
YoY Change	-22.98%	-31.04%	-32.88%
Goodwill
YoY Change
Intangibles		$514.6K	$495.6K
YoY Change		-6.69%	-10.1%
Long-Term Investments
YoY Change
Other Assets	$124.2K	$134.7K	$0.00
YoY Change		-32.66%
Total Long-Term Assets	$1.900M	$1.726M	$1.182M
YoY Change	77.68%	34.57%	-2.78%
TOTAL ASSETS
Total Short-Term Assets	$2.000M	$3.115M	$1.680M
Total Long-Term Assets	$1.900M	$1.726M	$1.182M
Total Assets	$3.900M	$4.841M	$2.862M
YoY Change	-13.92%	93.63%	17.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.700M	$2.093M	$2.421M
YoY Change	-29.01%	-40.2%	-16.43%
Accrued Expenses	$634.3K	$582.7K	$591.2K
YoY Change	3.63%	-47.03%	13.76%
Deferred Revenue
YoY Change
Short-Term Debt	$100.0K	$200.0K	$300.0K
YoY Change	-75.0%	-66.67%	-25.0%
Long-Term Debt Due	$98.11K	$100.0K	$99.32K
YoY Change	-1.96%	-94.12%	-90.63%
Total Short-Term Liabilities	$2.875M	$3.114M	$3.661M
YoY Change	-22.24%	-60.81%	-28.92%
LONG-TERM LIABILITIES
Long-Term Debt	$1.100M	$1.208M	$170.5K
YoY Change	400.61%	-8.44%	-90.06%
Other Long-Term Liabilities	$10.00M	$9.000M	$12.10M
YoY Change	16.28%	373.68%	611.76%
Total Long-Term Liabilities	$11.10M	$10.20M	$12.24M
YoY Change	25.72%	214.2%	251.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.875M	$3.114M	$3.661M
Total Long-Term Liabilities	$11.10M	$10.20M	$12.24M
Total Liabilities	$13.90M	$13.31M	$15.90M
YoY Change	10.96%	18.93%	84.13%
SHAREHOLDERS EQUITY
Retained Earnings		-$34.54M	-$36.29M
YoY Change			38.81%
Common Stock		$10.32K	$9.600K
YoY Change		191.63%	171.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$10.00M	-$8.472M	-$13.04M
YoY Change
Total Liabilities & Shareholders Equity	$3.900M	$4.841M	$2.862M
YoY Change	-13.92%	93.9%	17.98%

Cashflow Statement

Concept	2014 Q3	2014 Q2	2013 Q4
OPERATING ACTIVITIES
Net Income	-$3.301M	$239.1K	-$5.700M
YoY Change	77.81%	-114.43%	301.41%
Depreciation, Depletion And Amortization	$60.00K	$100.0K	$100.0K
YoY Change	-33.33%	11.11%	11.11%
Cash From Operating Activities	-$1.370M	-$910.0K	-$2.240M
YoY Change	-35.07%	89.58%	622.58%
INVESTING ACTIVITIES
Capital Expenditures	-$290.0K	-$260.0K	-$320.0K
YoY Change	190.0%	2500.0%	700.0%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$290.0K	-$260.0K	-$320.0K
YoY Change	190.0%	2500.0%	966.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	260.0K	2.870M	300.0K
YoY Change	-94.47%	7075.0%	25.0%
NET CHANGE
Cash From Operating Activities	-1.370M	-910.0K	-2.240M
Cash From Investing Activities	-290.0K	-260.0K	-320.0K
Cash From Financing Activities	260.0K	2.870M	300.0K
Net Change In Cash	-1.400M	1.700M	-2.260M
YoY Change	-156.22%	-477.78%	2160.0%
FREE CASH FLOW
Cash From Operating Activities	-$1.370M	-$910.0K	-$2.240M
Capital Expenditures	-$290.0K	-$260.0K	-$320.0K
Free Cash Flow	-$1.080M	-$650.0K	-$1.920M
YoY Change	-46.27%	38.3%	611.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2092915	USD
CY2014Q2	us-gaap	Assets Assets	4840687	USD
CY2013Q4	us-gaap	Assets Assets	2862121	USD
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	353641	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2420571	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	446329	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	16365	USD
CY2014Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	10198461	USD
CY2014Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	582691	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	554264	USD
CY2014Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	38800	USD
CY2013Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	75851	USD
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3114482	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3660855	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1971311	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	310140	USD
CY2014Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	166137	USD
CY2014Q2	us-gaap	Inventory Net InventoryNet	916826	USD
CY2014Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	60736	USD
CY2014Q2	us-gaap	Assets Current AssetsCurrent	3115010	USD
CY2014Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	722758	USD
CY2014Q2	us-gaap	Notes Payable NotesPayable	159986	USD
CY2013Q4	us-gaap	Notes Payable NotesPayable	278467	USD
CY2014Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	20372	USD
CY2013Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	24670	USD
CY2014Q2	us-gaap	Customer Deposits Current CustomerDepositsCurrent	67106	USD
CY2013Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	170777	USD
CY2014Q2	us-gaap	Interest Payable Current InterestPayableCurrent	54506	USD
CY2013Q4	us-gaap	Interest Payable Current InterestPayableCurrent	36935	USD
CY2014Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1207794	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	170496	USD
CY2014Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	8961351	USD
CY2014Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	514593	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	495608	USD
CY2013Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	12035816	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-237	USD
CY2013Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3324	USD
CY2013Q2	us-gaap	Cost Of Services CostOfServices	91342	USD
	us-gaap	Cost Of Revenue CostOfRevenue	744007	USD
	us-gaap	Cost Of Revenue CostOfRevenue	912489	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	214920	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	953627	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	200936	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	1679623	USD
CY2013Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	240561	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-925300	USD
	us-gaap	Taxes Other TaxesOther	16937	USD
	us-gaap	Taxes Other TaxesOther	46535	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1439378	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1521676	USD
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3536856	shares
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34541516	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36292532	USD
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	-8472256	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	-13038293	USD
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4840687	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2862121	USD
CY2014Q2	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	6009	USD
CY2013Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	16882	USD
CY2014Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	23307	USD
CY2013Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12239559	USD
CY2014Q2	us-gaap	Liabilities Liabilities	13312943	USD
CY2013Q4	us-gaap	Liabilities Liabilities	15900414	USD
CY2014Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	10315	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	9600	USD
CY2014Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	26058945	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23244639	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1918449	USD
CY2014Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	705196	shares
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1586691	USD
CY2014Q2	vuzi	Working Capital Deficit WorkingCapitalDeficit	528	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1260019	shares
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	941467	shares
CY2014Q2	us-gaap	Inventory Raw Materials And Purchased Parts Net Of Reserves InventoryRawMaterialsAndPurchasedPartsNetOfReserves	1131537	USD
CY2013Q4	us-gaap	Inventory Raw Materials And Purchased Parts Net Of Reserves InventoryRawMaterialsAndPurchasedPartsNetOfReserves	1094250	USD
CY2014Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	47983	USD
CY2013Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	153065	USD
CY2014Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	373214	USD
CY2013Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	280279	USD
CY2014Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	635908	USD
CY2013Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	573967	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1120521	USD
CY2014Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	609887	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	262371	USD
CY2013Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	188334	USD
CY2014Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	113371	USD
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	700195	USD
CY2014Q2	us-gaap	Sales Revenue Net SalesRevenueNet	723258	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	597291	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	807457	USD
CY2013Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	315280	USD
CY2014Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	416808	USD
	us-gaap	Cost Of Services CostOfServices	146716	USD
	us-gaap	Cost Of Services CostOfServices	105032	USD
CY2014Q2	us-gaap	Cost Of Services CostOfServices	45432	USD
CY2013Q2	us-gaap	Cost Of Revenue CostOfRevenue	406622	USD
CY2014Q2	us-gaap	Cost Of Revenue CostOfRevenue	462240	USD
	us-gaap	Gross Profit GrossProfit	695371	USD
	us-gaap	Gross Profit GrossProfit	609187	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	293573	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	261018	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	738721	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	692974	USD
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	421026	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	295552	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	562484	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	621322	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	602065	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	532561	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	188960	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	201143	USD
CY2013Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	90612	USD
CY2014Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	101438	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1107871	USD
CY2013Q2	us-gaap	Taxes Other TaxesOther	3241	USD
CY2014Q2	us-gaap	Taxes Other TaxesOther	25093	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-9745	USD
CY2014Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3713	USD
	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	294548	USD
	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	-3823818	USD
CY2013Q2	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	280261	USD
CY2014Q2	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	-1248556	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	47019	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	40214	USD
CY2013Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	37292	USD
CY2014Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	33889	USD
	us-gaap	Interest Expense InterestExpense	411238	USD
	us-gaap	Interest Expense InterestExpense	67367	USD
CY2013Q2	us-gaap	Interest Expense InterestExpense	231395	USD
CY2014Q2	us-gaap	Interest Expense InterestExpense	28877	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	239110	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.73
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-779487	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3669465	USD
CY2013Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-548865	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1164410	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2593034	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1751016	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1656736	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	239110	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
	us-gaap	Net Income Loss NetIncomeLoss	-2593034	USD
	us-gaap	Net Income Loss NetIncomeLoss	1751016	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-1656736	USD
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2014Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10315141	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9600453	shares
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10315141	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9600453	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.73
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3536856	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10135387	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3536856	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10285453	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3536856	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11395405	shares
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11226921	shares
CY2013	us-gaap	Increase Decrease In Deferred Revenue And Customer Advances And Deposits IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits	39700	USD
	us-gaap	Increase Decrease In Deferred Revenue And Customer Advances And Deposits IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits	56252	USD
CY2014Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	96238	USD
CY2013Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	91385	USD
CY2014Q2	vuzi	Accrued Compensation AccruedCompensation	404036	USD
CY2013Q4	vuzi	Accrued Compensation AccruedCompensation	360670	USD
CY2014Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	40000	USD
CY2013Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	69500	USD
CY2014Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	32982	USD
CY2013Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	31619	USD
CY2014Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9435	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1090	USD
CY2013Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	31619	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	44802	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	46265	USD
CY2014Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	32982	USD
	vuzi	Officers Compensation Payable Compounding Monthly Interest Rate OfficersCompensationPayableCompoundingMonthlyInterestRate	0.08	pure
	us-gaap	Depreciation Depreciation	188960	USD
	us-gaap	Depreciation Depreciation	201143	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	38694	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	38694	USD
	vuzi	Amortization Of Debt Issuance Costs AmortizationOfDebtIssuanceCosts	12573	USD
	vuzi	Amortization Of Debt Issuance Costs AmortizationOfDebtIssuanceCosts	3405	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	54940	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-48783	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-201080	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-36801	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1197	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-140200	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	615635	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-327655	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	105899	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	28427	USD
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-19268	USD
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-103671	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	6417	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-37051	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	100000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	0	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	316431	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	24513	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-738789	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1978999	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10051	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	83619	USD
	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	0	USD
CY2014Q1	vuzi	Class Of Warrant Or Right Exercised In Period ClassOfWarrantOrRightExercisedInPeriod	665000	shares
	us-gaap	Payments To Acquire Software PaymentsToAcquireSoftware	482196	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	26944	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	43821	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-36995	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-609636	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	36074	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	15171	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	148421	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	183624	USD
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	800000	USD
	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	3000000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	208237	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	138090	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	382884	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	790152	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4249806	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	14368	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1661171	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	66554	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	80922	USD
	us-gaap	Interest Paid InterestPaid	-85036	USD
	us-gaap	Interest Paid InterestPaid	-42854	USD
	vuzi	Discount Senior Convertible Debenture Attributed To Warrants DiscountSeniorConvertibleDebentureAttributedToWarrants	621012	USD
	vuzi	Discount Senior Convertible Debenture Attributed To Warrants DiscountSeniorConvertibleDebentureAttributedToWarrants	0	USD
	vuzi	Warrants Granted For Senior Convertible Debenture Issuance Costs WarrantsGrantedForSeniorConvertibleDebentureIssuanceCosts	66603	USD
	vuzi	Warrants Granted For Senior Convertible Debenture Issuance Costs WarrantsGrantedForSeniorConvertibleDebentureIssuanceCosts	0	USD
CY2014Q2	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	0	USD
CY2014Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	0	USD
CY2014Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	8961351	USD
CY2014Q2	us-gaap	Liabilities Fair Value Disclosure Recurring LiabilitiesFairValueDisclosureRecurring	8961351	USD
CY2014Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	8363751	USD
CY2014Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	7052566	USD
CY2013Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	12035816	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	294548	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3793616	USD
CY2013Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	280261	USD
CY2014Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1218354	USD
CY2014Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	5218092	shares
CY2014Q2	us-gaap	Long Term Debt LongTermDebt	1305900	USD
CY2013Q4	us-gaap	Long Term Debt LongTermDebt	269816	USD
CY2014Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	123408	USD
CY2014Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	123408	USD
CY2014Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	29559	USD
CY2014Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	3000000	USD
CY2014Q2	vuzi	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	0	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	11405522	USD
CY2014Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	30500000	USD
	vuzi	Operating Loss Carryforwards Expiration Year OperatingLossCarryforwardsExpirationYear	2018
	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b>Note 1  Basis of Presentation</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <b> </b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The accompanying unaudited Condensed Consolidated Financial Statements of Vuzix Corporation and Subsidiaries (“the Company") have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission. Accordingly, the unaudited Condensed Consolidated Financial Statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The condensed consolidated balance sheet as of December 31, 2013 was derived from the audited Consolidated Financial Statements in Form 10-K.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The accompanying Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of the Company as of December 31, 2013, as reported in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	7147775	shares
CY2014Q2	vuzi	Class Of Warrant Or Right Exercised In Period ClassOfWarrantOrRightExercisedInPeriod	61896	shares
CY2014Q1	vuzi	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	0	shares
CY2014Q2	vuzi	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	0	shares
CY2014Q1	vuzi	Class Of Warrant Or Right Expired In Period ClassOfWarrantOrRightExpiredInPeriod	57668	shares
CY2014Q2	vuzi	Class Of Warrant Or Right Expired In Period ClassOfWarrantOrRightExpiredInPeriod	0	shares
CY2014Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6425107	shares
CY2014Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6363211	shares
	vuzi	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Terms ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerms	P3Y8M12D
	invest	Investment Warrants Exercise Price InvestmentWarrantsExercisePrice	2.74
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	214518	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	214518	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.72
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.72
CY2013Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	1.71
CY2013Q4	vuzi	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperLimit	17.50
	vuzi	Share Based Compensation Arrangement By Share Based Payment Award Options Expired And Forfeited Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredAndForfeitedExercisePrice	0
CY2014Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	1.71
CY2014Q2	vuzi	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Balance ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitBalance	17.50
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	209222	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	9.69
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y7M6D
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2014Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	50524	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P7M6D
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	5296	shares
	vuzi	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	10.74
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P6Y1M6D
CY2014Q2	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	15222	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2014-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Registrant Name EntityRegistrantName	Vuzix Corp
	dei	Entity Central Index Key EntityCentralIndexKey	0001463972
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Trading Symbol TradingSymbol	VUZI
CY2014Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10563196	shares
CY2014Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	134685	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	USD
	vuzi	Discount On Senior Convertible Debt Attributed To Embedded Conversion Price Adjustment Option DiscountOnSeniorConvertibleDebtAttributedToEmbeddedConversionPriceAdjustmentOption	1938988	USD
	vuzi	Fair Value Of Debt Embedded Conversion Price Adjustment Option FairValueOfDebtEmbeddedConversionPriceAdjustmentOption	1908786	USD
CY2014Q2	vuzi	Fair Value Of Debt Embedded Conversion Price Adjustment Option FairValueOfDebtEmbeddedConversionPriceAdjustmentOption	1938988	USD
CY2014Q2	us-gaap	Convertible Debt ConvertibleDebt	3000000	USD
CY2014Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3276375	USD
CY2014Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	1970475	USD

Files In Submission

Name	View Source	Status
0001144204-14-050138-index-headers.html	Edgar Link	pending
0001144204-14-050138-index.html	Edgar Link	pending
0001144204-14-050138.txt	Edgar Link	pending
0001144204-14-050138-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v385650_10-q.htm	Edgar Link	pending
v385650_ex31-1.htm	Edgar Link	pending
v385650_ex31-2.htm	Edgar Link	pending
v385650_ex32-1.htm	Edgar Link	pending
v385650_ex32-2.htm	Edgar Link	pending
vuzi-20140630.xml	Edgar Link	completed
vuzi-20140630.xsd	Edgar Link	pending
vuzi-20140630_cal.xml	Edgar Link	unprocessable
vuzi-20140630_def.xml	Edgar Link	unprocessable
vuzi-20140630_lab.xml	Edgar Link	unprocessable
vuzi-20140630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VUZI
Vuzix Corp Stock $vuzi

2014 Q3 Form 10-Q Financial Statement

#000114420414050138 Filed on August 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VUZI Vuzix Corp Stock $vuzi

2014 Q3 Form 10-Q Financial Statement

#000114420414050138 Filed on August 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VUZI
Vuzix Corp Stock $vuzi